Word

KINTOR

Status

Registered

Status Code

700

Status Date

Tuesday, October 13, 2020

Serial Number

88125988

Registration Number

6172273

Registration Date

Tuesday, October 13, 2020

Mark Type

3000

Filing Date

Thursday, September 20, 2018

Published for Opposition

Tuesday, November 26, 2019

Trademark Owner History

Kintor Pharmaceutical Limited - Original Registrant

Classifications

5 Medicines for treatment of cancer; sachets for pharmaceutical purposes, medicines in the form of capsules, chemico-pharmaceutical preparations, drugs for medical purposes, chemical preparations for pharmaceutical purposes, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; pharmaceutical products for the prevention, diagnosis, treatment and adjunctive therapy of cancer, cardiovascular disease, nervous system diseases, infectious diseases, respiratory diseases, endocrine and metabolic diseases, mental disorder, skin disease, diseases of the blood system, digestive system diseases, immune system diseases, diseases of genitourinary system, ocular diseases, otolaryngology and dentistry diseases, musculoskeletal and connective tissue diseases, nutritional diseases, diseases caused by external factors, namely, poisoning and injury; compounds for treating cancer; pharmaceuticals, medical and veterinary preparations for the prevention, diagnosis, treatment and adjunctive therapy of cancer, cardiovascular disease, nervous system diseases, infectious diseases, respiratory diseases, endocrine and metabolic diseases, mental disorder, skin disease, diseases of the blood system, digestive system diseases, immune system diseases, diseases of genitourinary system, ocular diseases, otolaryngology and dentistry diseases, musculoskeletal and connective tissue diseases, nutritional diseases, diseases caused by external factors, namely, poisoning and injury; sanitary preparations for medical purposes; dietetic food and substances, namely, dietetic foods, sugar substitutes, nutritional beverages, and dietary supplements for weight loss adapted for medical and veterinary use; food for babies; dietary supplements for humans and animals; plasters and materials, namely, gauze for medical dressings; materials for dental fillings and for sealing purposes; dental wax; disinfectants; preparations for destroying vermin; fungicides; herbicides

35 Retail pharmacy services; advertising services; business management; business administration services; providing office functions; information, advisory and consultancy services relating to all the aforesaid services

42 Scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceutical products; biotechnology research; biochemistry and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; testing services for assessing the efficacy and safety of pharmaceuticals; preparation of reports relating to scientific research; analytical medical and scientific laboratory services; medical and scientific laboratory research and analysis; development of products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; scientific and technological services in the field of pharmaceuticals and research and design relating thereto, namely, consulting and advisory services, CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) services; industrial analysis and research services in the field of pharmaceuticals; design and development of computer hardware and software; information, advisory and consultancy services relating to all the aforesaid services

44 Pharmaceutical compounding services; providing medical information and information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical advice in the field of medicine, pharmacology, medical analysis and diagnostics; provision of medical services in the field of alternative medicine; providing medical information relating to medicine, pharmacology and medical diagnosis; medicine and treatment prescription services, namely, services relating to the diagnosis of illness and prescription of medicine; medicine and treatment prescription services, namely, home health care services, managed health care services; physical therapy services; medical diagnostic testing, monitoring and reporting services; medical services; veterinary services; hygienic and beauty salon and consultation services for human beings and animals; medicine and treatment prescription services, namely, insecticide spraying, vermin extermination for agriculture, horticulture and forestry; information, advisory and consultancy services relating to all the aforesaid services

Color is not claimed as a feature of the mark.
"PHARMACEUTICALS"
The mark consists of the word "KINTOR"; the letter "O" of the word "KINTOR" contains four white Chinese characters on a black background.
The non-Latin characters in the mark transliterate to "kai tuo yao ye" and this means "expand pharmaceuticals" or "explore pharmaceuticals" in English.
The English translation of "kai tuo" in the mark is "expand" or "explore", and the English translation of "yao ye" in the mark is "pharmaceuticals".

Trademark Events

Oct 13, 2020

Registered-Principal Register

Sep 4, 2020

1(B) Basis Deleted; Proceed To Registration

Jul 10, 2020

Notice Of Allowance Cancelled

Sep 4, 2020

Case Assigned To Intent To Use Paralegal

Jul 10, 2020

Teas Delete 1(B) Basis Received

Jul 9, 2020

Applicant/Correspondence Changes (Non-Responsive) Entered

Jul 9, 2020

Teas Change Of Correspondence Received

Jul 9, 2020

Teas Change Of Owner Address Received

Feb 14, 2020

Changes/Corrections After Pub Approval Entered

Feb 12, 2020

Assigned To Petition Staff

Jan 21, 2020

Noa E-Mailed - Sou Required From Applicant

Jan 3, 2020

Teas Post Publication Amendment Received

Nov 26, 2019

Official Gazette Publication Confirmation E-Mailed

Nov 26, 2019

Published For Opposition

Nov 6, 2019

Notification Of Notice Of Publication E-Mailed

Oct 20, 2019

Approved For Pub - Principal Register

Oct 15, 2019

Teas/Email Correspondence Entered

Oct 15, 2019

Correspondence Received In Law Office

Oct 14, 2019

Assigned To Lie

Oct 9, 2019

Teas Response To Suspension Inquiry Received

Jul 13, 2019

Notification Of Letter Of Suspension E-Mailed

Jul 13, 2019

Letter Of Suspension E-Mailed

Jul 13, 2019

Suspension Letter Written

Jul 9, 2019

Teas/Email Correspondence Entered

Jul 8, 2019

Correspondence Received In Law Office

Jul 8, 2019

Teas Response To Office Action Received

Jan 7, 2019

Notification Of Non-Final Action E-Mailed

Jan 7, 2019

Non-Final Action E-Mailed

Jan 7, 2019

Non-Final Action Written

Jan 2, 2019

Assigned To Examiner

Sep 28, 2018

Notice Of Design Search Code E-Mailed

Sep 27, 2018

New Application Office Supplied Data Entered In Tram

Sep 24, 2018

New Application Entered In Tram